24-Sep-2026 - Yahoo Finance Is Bio-Techne Stock Outperforming the Nasdaq? Bio-Techne has outperformed the Nasdaq over the past year, but analysts are cautious about the stock’s prospects.
22-Sep-2026 - Yahoo Finance 3 Reasons to Sell TECH and 1 Stock to Buy Instead Bio-Techne has had an impressive run over the past six months as its shares have beaten the S&P 500 by 21.5%. The stock now trades at $72.56, marking a 39.5% gain. This was partly due to its solid ...
14-Sep-2026 - Yahoo Finance Bio Techne (TECH) And The Valuation Case Behind Its Recent Rebound Bio-Techne (TECH) has drawn fresh attention after recent trading left the share price at $72.27, with performance over the past month roughly flat and the past 3 months showing a strong double digit ...
28-Aug-2026 - Morningstar Bio-Techne To Be Acquired by Merck KGaA Bio-Techne is a market leader in proteins, immunoassays, clinical diagnostic controls, and other reagents that are crucial for the academic, biopharmaceutical, and diagnostic markets. On June 25, 2026 ...
13-Aug-2026 - Yahoo Finance Bio-Techne Corrects Dividend Announcement Bio-Techne Corporation (NASDAQ: TECH) is issuing a correction to its dividend announcement released yesterday. The initial version incorrectly stated the shareholder of record date as August 17, 2026.
12-Aug-2026 - StockStory.org Bio-Techne (NASDAQ:TECH) surprises with Q2 CY2026 sales Life sciences company Bio-Techne (NASDAQ:TECH) reported Q2 CY2026 results , with sales up 1.3% year on year to $321.2 million. Its non-GAAP profit of $0.52 per share was in line with analysts’ ...
12-Aug-2026 - AOL Bio-Techne Declares Dividend For more information on Bio-Techne and its brands, please visit or follow the company on social media at LinkedIn , X , or YouTube . Forward Looking Statements: Our press releases may contain forward ...
24-Sep-2026 - Yahoo Finance Is Bio-Techne Stock Outperforming the Nasdaq? Bio-Techne has outperformed the Nasdaq over the past year, but analysts are cautious about the stock’s prospects.
22-Sep-2026 - Yahoo Finance 3 Reasons to Sell TECH and 1 Stock to Buy Instead Bio-Techne has had an impressive run over the past six months as its shares have beaten the S&P 500 by 21.5%. The stock now trades at $72.56, marking a 39.5% gain. This was partly due to its solid ...
14-Sep-2026 - Yahoo Finance Bio Techne (TECH) And The Valuation Case Behind Its Recent Rebound Bio-Techne (TECH) has drawn fresh attention after recent trading left the share price at $72.27, with performance over the past month roughly flat and the past 3 months showing a strong double digit ...
28-Aug-2026 - Morningstar Bio-Techne To Be Acquired by Merck KGaA Bio-Techne is a market leader in proteins, immunoassays, clinical diagnostic controls, and other reagents that are crucial for the academic, biopharmaceutical, and diagnostic markets. On June 25, 2026 ...
13-Aug-2026 - Yahoo Finance Bio-Techne Corrects Dividend Announcement Bio-Techne Corporation (NASDAQ: TECH) is issuing a correction to its dividend announcement released yesterday. The initial version incorrectly stated the shareholder of record date as August 17, 2026.
12-Aug-2026 - StockStory.org Bio-Techne (NASDAQ:TECH) surprises with Q2 CY2026 sales Life sciences company Bio-Techne (NASDAQ:TECH) reported Q2 CY2026 results , with sales up 1.3% year on year to $321.2 million. Its non-GAAP profit of $0.52 per share was in line with analysts’ ...
12-Aug-2026 - AOL Bio-Techne Declares Dividend For more information on Bio-Techne and its brands, please visit or follow the company on social media at LinkedIn , X , or YouTube . Forward Looking Statements: Our press releases may contain forward ...
